menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

Mammothbio-Logo

Mammoth Biosciences

Developed a CRISPR-based platform for disease to enable the detection of any type of nucleic acid.

MapLight

Develops targeted treatments for brain disorders using advanced technology to identify and modulate neural circuits.

Mariana Oncology

Develops precision radiopharmaceutical therapies that combine radioactive isotopes with targeting molecules to treat cancer effectively.

Matchpoint Therapeutics

Biotech company develops precision small molecule medicines targeting immune diseases through innovative covalent bonding technology.

Medable Inc.-Logo

Medable

Global cloud platform for decentralized clinical trials.

Mercy BioAnalytics

Develops liquid biopsy platform using extracellular vesicles for early cancer detection through blood-based diagnostic tests.

Metabolon

Biochemical profiling platform that provides analysis of complex biological samples.

Mirvie

Predicts pregnancy complications early by analyzing RNA messages.

MOBILion Systems

Develops high-resolution ion mobility mass spectrometry technology for advanced molecular analysis in pharmaceutical and environmental testing.

MoMa Therapeutics

Biotech company develops precision medicines by targeting molecular machines involved in disease processes to advance drug discovery.

Mozart Therapeutics

Develops biologic therapies targeting CD8 Treg cells to restore immune system function and treat autoimmune diseases

MycoMedica Life Sciences

Develops and produces medicinal mushroom-based wellness products, offering natural health solutions through innovative fungi formulations.

Myeloid Therapeutics

Develops targeted immunotherapies for cancer and autoimmune diseases using proprietary technology to enhance immune system responses.

Nested Therapeutics

Develops precision medicines targeting genetic mutations to create more effective cancer treatments using advanced scientific approaches.

Neumora

Develops innovative treatments for neuropsychiatric diseases using advanced drug discovery technology to target biological mechanisms.

Neuron23 Inc-Logo

Neuron23

Biotechnology company focused on developing personalized medicines for genetic disorders.

NewLimit

Develops epigenetic reprogramming therapies.

NextPoint

Biotech company develops innovative cancer immunotherapy treatments targeting the B7-H7 pathway to help patients unresponsive to current options.